MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT)

132 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q3 2025.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 70.1M shares of 107M outstanding shares and own 65.59% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.98M shares), CADIAN CAPITAL MANAGEMENT, LP (8.23M shares), MIRABELLA FINANCIAL SERVICES LLP (8.2M shares), MORGAN STANLEY (6.7M shares), VANGUARD GROUP INC (5.59M shares), Vitruvian Partners LLP (5.04M shares), Mudita Advisors LLP (3.37M shares), AXA Investment Managers S.A. (2.77M shares), GEODE CAPITAL MANAGEMENT, LLC (2.56M shares), and STATE STREET CORP (2.27M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.